Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BUCY+VP-16 vs BUCY in DLBCL undergoing Auto-HSCT
NCT03229616Phase 3Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jul 2017
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etoposide in diffuse large B-cell lymphoma (DLBCL), sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
etoposide
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT03229616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03229616.